Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The severity of MUSK pathogenic variants is predicted by the protein domain they disrupt. | HGG Adv | 2024 | 38566418 | PubTator, text mining | PubMed |
| Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan. | Neurol Clin Pract | 2024 | 38544885 | PubTator, text mining | PubMed |
| MuSK Myasthenia Gravis-Potential Pathomechanisms and Treatment Directed against Specific Targets. | Cells | 2024 | 38534400 | PubTator, text mining | PubMed |
| Prevention of age-related neuromuscular junction degeneration in sarcopenia by low-magnitude high-frequency vibration. | Aging Cell | 2024 | 38532712 | PubTator, text mining | PubMed |
| Chemical composition and microbiota changes across musk secretion stages of forest musk deer. | Front Microbiol | 2024 | 38505545 | PubTator, text mining | PubMed |
| Myasthenia gravis-Pathophysiology, diagnosis, and treatment. | Handb Clin Neurol | 2024 | 38494283 | PubTator, text mining | PubMed |
| Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari. | Muscle Nerve | 2024 | 38456240 | PubTator, text mining | PubMed |
| Motor neurons and endothelial cells additively promote development and fusion of human iPSC-derived skeletal myocytes. | Skelet Muscle | 2024 | 38454511 | PubTator, text mining | PubMed |
| "De Novo" Hypercapnic Respiratory Failure Unmasking Neuromuscular Disorders: Experiences From a Tertiary Care Center and Review of Literature. | J Clin Neuromuscul Dis | 2024 | 38441928 | PubTator, text mining | PubMed |
| B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis. | EMBO Mol Med | 2024 | 38409527 | PubTator, text mining | PubMed |
| Independent risk factors for in-hospital outcome of myasthenic crisis: a prospective cohort study. | Ther Adv Neurol Disord | 2024 | 38344193 | PubTator, text mining | PubMed |
| Triple-seronegative myasthenia gravis: clinical and epidemiological characteristics. | Arq Neuropsiquiatr | 2024 | 38316426 | PubTator, text mining | PubMed |
| Comparison of three methods for the detection of antibodies against muscle-specific kinase. | J Immunol Methods | 2024 | 38311009 | PubTator, text mining | PubMed |
| Assessing the comparative efficacy of plasmapheresis and Intravenous immunoglobulin in myasthenia gravis treatment: A systematic review and meta-analysis. | J Clin Neurosci | 2024 | 38306763 | PubTator, text mining | PubMed |
| Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy. | Lipids Health Dis | 2024 | 38302980 | PubTator, text mining | PubMed |
| Thymoma negatively affects the neurological outcome of myasthenia gravis after thymectomy: a propensity score matching study. | J Cardiothorac Surg | 2024 | 38297367 | PubTator, text mining | PubMed |
| Mendelian randomization study revealed a gut microbiota-neuromuscular junction axis in myasthenia gravis. | Sci Rep | 2024 | 38291090 | PubTator, text mining | PubMed |
| Registered trials on novel therapies for myasthenia gravis: a cross-sectional study on ClinicalTrials.gov. | Sci Rep | 2024 | 38267496 | PubTator, text mining | PubMed |
| Detection of Genomic Structural Variations Associated with Drug Sensitivity and Resistance in Acute Leukemia. | Cancers (Basel) | 2024 | 38254907 | PubTator, text mining | PubMed |
| National Multicenter Study on the Comparison of Robotic and Open Thymectomy for Thymic Neoplasms in Myasthenic Patients: Surgical, Neurological and Oncological Outcomes. | Cancers (Basel) | 2024 | 38254894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=14